Copper-Catalyzed N-Arylation of 2-Pyridones Employing Diaryliodonium Salts at Room Temperature.

A new and mild synthetic approach for the N-arylation of 2-pyridones with diaryliodonium salts has been developed. Most reactions proceed readily at room temperature in the presence of 10 mol % of copper chloride. As a result, a wide range of N-arylpyridine-2-ones were synthesized in yields of 23% to 99%. With this method, an antifibrotic drug, Pirfenidone, was successfully synthesized in 99% yield within 30 min at room temperature.

[1]  Akira Yoshimura,et al.  Advances in Synthetic Applications of Hypervalent Iodine Compounds. , 2016, Chemical reviews.

[2]  Klára Aradi,et al.  Diaryliodonium Salts in Organic Syntheses: A Useful Compound Class for Novel Arylation Strategies , 2016, Synlett.

[3]  B. Olofsson.  Arylation with Diaryliodonium Salts. , 2015, Topics in current chemistry.

[4]  Won-Suk Kim,et al.  Copper-catalyzed N-arylation of tert-butyl N-sulfonylcarbamates with diaryliodonium salts at room temperature , 2015 .

[5]  Roman Manetsch,et al.  Metal-free arylation of ethyl acetoacetate with hypervalent diaryliodonium salts: an immediate access to diverse 3-aryl-4(1H)-quinolones. , 2015, The Journal of organic chemistry.

[6]  A. Beydoun,et al.  Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel , 2014, Epilepsy & Behavior Case Reports.

[7]  A. Gagnon,et al.  Synthesis of highly functionalized diaryl ethers by copper-mediated O-arylation of phenols using trivalent arylbismuth reagents. , 2014, Chemistry.

[8]  T. Lavergne,et al.  Natural-like replication of an unnatural base pair for the expansion of the genetic alphabet and biotechnology applications. , 2014, Journal of the American Chemical Society.

[9]  S. Fauser,et al.  Clinical course of intoxication with the new anticonvulsant drug perampanel , 2013, Epileptic disorders : international epilepsy journal with videotape.

[10]  F. Himo,et al.  Arylation with Unsymmetrical Diaryliodonium Salts: A Chemoselectivity Study , 2013, Chemistry.

[11]  Bo Yang,et al.  Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs. , 2013, European journal of medicinal chemistry.

[12]  B. Collins,et al.  Copper-catalyzed arylative Meyer-Schuster rearrangement of propargylic alcohols to complex enones using diaryliodonium salts. , 2013, Angewandte Chemie.

[13]  X. Ribas,et al.  The role of organometallic copper(III) complexes in homogeneous catalysis , 2013 .

[14]  Wei Lu,et al.  Cu-mediated selective O-arylation on C-6 substituted pyridin-2-ones , 2013 .

[15]  T. Hanada,et al.  Discovery of 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (perampanel): a novel, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist. , 2012, Journal of medicinal chemistry.

[16]  D. Boykin,et al.  Pirfenidone structural isosteres: design, synthesis and spectral study , 2012 .

[17]  Melanie S. Sanford,et al.  High-valent organometallic copper and palladium in catalysis , 2012, Nature.

[18]  M. Kuriyama,et al.  Copper(II)-catalyzed monoarylation of vicinal diols with diaryliodonium salts. , 2012, Chemistry.

[19]  F. Carroll,et al.  A Practical, Laboratory-ScaleSynthesis of Perampanel , 2012 .

[20]  K. Kossen,et al.  Antifibrotic activities of pirfenidone in animal models , 2011, European Respiratory Review.

[21]  Liuqing Wei,et al.  Mild addition of nucleophiles to pyridine-N-oxides. , 2011, Organic letters.

[22]  A. Azuma.  Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis , 2010, Expert review of respiratory medicine.

[23]  R. Bois,et al.  Strategies for treating idiopathic pulmonary fibrosis , 2010, Nature Reviews Drug Discovery.

[24]  Jilu Feng,et al.  Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives. , 2010, Journal of medicinal chemistry.

[25]  M. Cho,et al.  Pirfenidone: an anti-fibrotic therapy for progressive kidney disease , 2010, Expert opinion on investigational drugs.

[26]  R. Bedford,et al.  Palladium-catalysed ortho-arylation of carbamate-protected phenols. , 2009, Organic & biomolecular chemistry.

[27]  S. Rabindran,et al.  Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4. , 2009, Journal of medicinal chemistry.

[28]  D. Aili,et al.  Regiospecific one-pot synthesis of diaryliodonium tetrafluoroborates from arylboronic acids and aryl iodides. , 2008, The Journal of organic chemistry.

[29]  Mingzhao Zhu,et al.  Efficient and General One‐Pot Synthesis of Diaryliodonium Triflates: Optimization, Scope and Limitations , 2007 .

[30]  B. Olofsson,et al.  High-yielding one-pot synthesis of diaryliodonium triflates from arenes and iodine or aryl iodides. , 2007, Chemical communications.

[31]  S. Buchwald,et al.  Cu-catalyzed N- and O-arylation of 2-, 3-, and 4-hydroxypyridines and hydroxyquinolines. , 2007, Organic letters.

[32]  T. Mukaiyama,et al.  N-Arylation of Pyridin-2(1H)-ones with Pentavalent Organobismuth Reagents under Copper-Free Conditions , 2006 .

[33]  A. Dosanjh.  Pirfenidone: anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients. , 2006, European journal of pharmacology.

[34]  M. Sanford,et al.  Oxidative C-H activation/C-C bond forming reactions: synthetic scope and mechanistic insights. , 2005, Journal of the American Chemical Society.

[35]  Darryl D Dixon,et al.  An efficient copper-catalyzed coupling reaction of pyridin-2-ones with aryl and heterocyclic halides based on Buchwald's protocol , 2004 .

[36]  H. Oku,et al.  A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level. , 2002, European journal of pharmacology.

[37]  P. Lam,et al.  Copper-promoted CN bond cross-coupling with phenylstannane , 2002 .

[38]  P. Lam,et al.  Copper-catalyzed general CN and CO bond cross-coupling with arylboronic acid , 2001 .

[39]  W. Mederski,et al.  N-aryl heterocycles via coupling reactions with arylboronic acids , 1999 .

[40]  G. Raghu,et al.  Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent , Pirfenidone Results of a Prospective , Open-label Phase II Study , 1999 .

[41]  S. Sieburth,et al.  Selective Intermolecular Photo-[4 + 4]-cycloaddition with 2-Pyridone Mixtures. 2. Preparation of (1α,2β,5β,6α)-3-Butyl- 9-methoxy-3,7-diazatricyclo[4.2.2.22,5]dodeca-9,11-diene-4,8-dione , 1999 .

[42]  T. Ukita,et al.  A Facile Copper-Catalyzed Ullmann Condensation : N-Arylation of Heterocyclic Compounds Containing an -NHCO- Moiety , 1997 .

[43]  H. Azima,et al.  The effect of amphenidone (Dornwal) in anxiety states: a multi-blind study. , 1961, The American journal of psychiatry.